Expression of concern: Phosphorylation drives an apoptotic protein to activate antiapoptotic genes: paradigm of influenza a matrix 1 protein function (Journal of Biological Chemistry (2013) 288 (14554–14568) DOI: 10.1074/jbc.M112.447086);Phosphorylation drives an apoptotic protein to activate antiapoptotic genes: Paradigm of influenza a matrix 1 protein function

Journal of Biological Chemistry

Volumn 288, Issue 20, 2013, Pages 14554-14568

  Halder, Umesh Chandra ^a   Bhowmick, Rahul ^a   Mukherjee, Tapasi Roy ^a   Nayak, Mukti Kant ^b   Chawla Sarkar, Mamta ^a  

^a NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^b UNIVERSITY OF CALCUTTA   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ANALYSIS; ALKYLATION; CELL DEATH; ENZYMES; PHOSPHORYLATION; VIRUSES;

APOPTOTIC PROTEINS; DNA METHYLTRANSFERASES; INNATE IMMUNE RESPONSE; NUCLEAR FACTOR KAPPAB; NUCLEAR LOCALIZATION SIGNAL; NUCLEAR TRANSLOCATIONS; PROTEASOMAL DEGRADATION; PROTEIN KINASE C INHIBITORS;

TRANSCRIPTION;

CALPHOSTIN C; DAXX PROTEIN; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; FLICE INHIBITORY PROTEIN; INFLUENZA A MATRIX 1 PROTEIN; MATRIX PROTEIN; PHOSPHOTRANSFERASE; PROTEASOME; TRANSCRIPTION FACTOR RELB; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL NUCLEUS; CELL SURVIVAL; CFLIP GENE; CIAP1 GENE; CIAP2 GENE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; ENZYME DEGRADATION; GENE; GENE ACTIVATION; HUMAN; HUMAN CELL; INFLUENZA VIRUS A; INNATE IMMUNITY; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; UBIQUITINATION; UPREGULATION; VIRUS CELL INTERACTION; VIRUS INFECTION;

EID: 84877899599     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.EC119.011071     Document Type: Erratum

References (64)

1. Benedict, C. A., Norris, P. S., and Ware, C. F. (2002) To kill or be killed: viral evasion of apoptosis. Nat. Immunol. 3, 1013-1018 (Pubitemid 35363651)
2. Lamkanfi, M., and Dixit, V. M. (2010) Manipulation of host cell death pathways during microbial infections. Cell Host Microbe 8, 44-54
3. Li, J., and Yuan, J. (2008) Caspases in apoptosis and beyond. Oncogene 27, 6194-6206
4. Kurokawa, M., and Kornbluth, S. (2009) Caspases and kinases in a death grip. Cell 138, 838-854
5. Boyd, J. M., Malstrom, S., Subramanian, T., Venkatesh, L. K., Schaeper, U., Elangovan, B., D'Sa-Eipper, C., and Chinnadurai, G. (1994) Adenovirus E1B 19 kDa and bcl-2 proteins interact with a common set of cellular proteins. Cell 79, 341-351 (Pubitemid 24324923)
6. Perez, D., and White, E. (2000) TNF-α signals apoptosis through a Bid-dependent conformational change in Bax that is inhibited by E1B 19K. Mol. Cell 6, 53-63
7. Henderson, S., Huen, D., Rowe, M., Dawson, C., Johnson, G., and Rickinson, A. (1993) Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. U.S.A. 90, 8479-8483 (Pubitemid 23277692)
8. Sarid, R., Sato, T., Bohenzky, R. A., Russo, J. J., and Chang, Y. (1997) Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat. Med. 3, 293-298 (Pubitemid 27112926)
9. Sato, Y., Kamura, T., Shirata, N., Murata, T., Kudoh, A., Iwahori, S., Nakayama, S., Isomura, H., Nishiyama, Y., and Tsurumi, T. (2009) Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complex. PLoS Pathog. 5, e1000530
10. Querido, E., Blanchette, P., Yan, Q., Kamura, T., Morrison, M., Boivin, D., Kaelin, W. G., Conaway, R. C., Conaway, J. W., and Branton, P. E. (2001) Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev. 15, 3104-3117 (Pubitemid 33115675)
11. Jiang, D., Srinivasan, A., Lozano, G., and Robbins, P. D. (1993) SV40 T antigen abrogates p53-mediated transcriptional activity. Oncogene 8, 2805-2812 (Pubitemid 23279109)
12. Lilyestrom, W., Klein, M. G., Zhang, R., Joachimiak, A., and Chen, X. S. (2006) Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressor. Genes Dev. 20, 2373-2382 (Pubitemid 44320386)
13. Elmore, L. W., Hancock, A. R., Chang, S. F., Wang, X. W., Chang, S., Callahan, C. P., Geller, D. A., Will, H., and Harris, C. C. (1997) Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc. Natl. Acad. Sci. U.S.A. 94, 14707-14712 (Pubitemid 28041438)
14. Thomas, M., Massimi, P., Jenkins, J., and Banks, L. (1995) HPV-18 E6 mediated inhibition of p53 DNA binding activity is independent of E6 induced degradation. Oncogene 10, 261-268
15. Lan, K. H., Sheu, M. L., Hwang, S. J., Yen, S. H., Chen, S. Y., Wu, J. C., Wang, Y. J., Kato, N., Omata, M., Chang, F. Y., and Lee, S. D. (2002) HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. Oncogene 21, 4801-4811 (Pubitemid 34879455)
16. Jabbour, A. M., Ekert, P. G., Coulson, E. J., Knight, M. J., Ashley, D. M., and Hawkins, C. J. (2002) The p35 relative, p49, inhibits mammalian and Drosophila caspases including DRONC and protects against apoptosis. Cell Death Differ. 9, 1311-1320 (Pubitemid 36097701)
17. Zoog, S. J., Schiller, J. J., Wetter, J. A., Chejanovsky, N., and Friesen, P. D. (2002) Baculovirus apoptotic suppressor P49 is a substrate inhibitor of initiator caspases resistant to P35 in vivo. EMBO J. 21, 5130-5140
18. Bump, N. J., Hackett, M., Hugunin, M., Seshagiri, S., Brady, K., Chen, P., Ferenz, C., Franklin, S., Ghayur, T., and Li, P. (1995) Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science 269, 1885-1888
19. Miura, M., Friedlander, R. M., and Yuan, J. (1995) Tumor necrosis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway. Proc. Natl. Acad. Sci. U.S.A. 92, 8318-8322
20. Danial, N. N., and Korsmeyer, S. J. (2004) Cell death: critical control points. Cell 116, 205-219 (Pubitemid 38167313)
21. Gyrd-Hansen, M., and Meier, P. (2010) IAPs: From caspase inhibitors to modulators of NF-κB, inflammation and cancer. Nat. Rev. Cancer 10, 561-574
22. Srinivasula, S. M., and Ashwell, J. D. (2008) IAPs: what's in a name? Mol. Cell 30, 123-135 (Pubitemid 351626688)
23. Vaux, D. L., and Silke, J. (2005) IAPs, RINGs and ubiquitylation. Nat. Rev. Mol. Cell Biol. 6, 287-297 (Pubitemid 40516895)
24. Rippo, M. R., Moretti, S., Vescovi, S., Tomasetti, M., Orecchia, S., Amici, G., Catalano, A., and Procopio, A. (2004) FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells. Oncogene 23, 7753-7760 (Pubitemid 39457025)
25. Hoffmann, A., Leung, T. H., and Baltimore, D. (2003) Genetic analysis of NF-κB/Rel transcription factors defines functional specificities. EMBO J. 22, 5530-5539 (Pubitemid 37279962)
26. Jacque, E., Tchenio, T., Piton, G., Romeo, P. H., and Baud, V. (2005) RelA repression of RelB activity induces selective gene activation downstream of TNF receptors. Proc. Natl. Acad. Sci. U.S.A. 102, 14635-14640 (Pubitemid 41457108)
27. Weih, F., Carrasco, D., Durham, S. K., Barton, D. S., Rizzo, C. A., Ryseck, R. P., Lira, S. A., and Bravo, R. (1995) Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 80, 331-340
28. Burkly, L., Hession, C., Ogata, L., Reilly, C., Marconi, L. A., Olson, D., Tizard, R., Cate, R., and Lo, D. (1995) Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 373, 531-536
29. Ryseck, R. P., Bull, P., Takamiya, M., Bours, V., Siebenlist, U., Dobrzanski, P., and Bravo, R. (1992) RelB, a new Rel family transcription activator that can interact with p50-NF-κB. Mol. Cell. Biol. 12, 674-684
30. Hoffmann, A., and Baltimore, D. (2006) Circuitry of nuclear factor κB signaling. Immunol. Rev. 210, 171-186
31. Drané, P., Ouararhni, K., Depaux, A., Shuaib, M., and Hamiche, A. (2010) The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3. Genes Dev. 24, 1253-1265
32. Lewis, P. W., Elsaesser, S. J., Noh, K. M., Stadler, S. C., and Allis, C. D. (2010) Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres. Proc. Natl. Acad. Sci. U.S.A. 107, 14075-14080
33. Elsässer, S. J., Huang, H., Lewis, P. W., Chin, J. W., Allis, C. D., and Patel, D. J. (2012) DAXX envelops a histone H3.3-H4 dimer for H3.3-specific recognition. Nature 491, 560-565
34. Ecsedy, J. A., Michaelson, J. S., and Leder, P. (2003) Homeodomain-interacting protein kinase 1 modulates Daxx localization, phosphorylation, and transcriptional activity. Mol. Cell. Biol. 23, 950-960 (Pubitemid 36133513)
35. Muromoto, R., Sugiyama, K., Takachi, A., Imoto, S., Sato, N., Yamamoto, T., Oritani, K., Shimoda, K., and Matsuda, T. (2004) Physical and functional interactions between Daxx and DNA methyltransferase 1-associated protein, DMAP1. J. Immunol. 172, 2985-2993 (Pubitemid 38263686)
36. Xue, Y., Gibbons, R., Yan, Z., Yang, D., McDowell, T. L., Sechi, S., Qin, J., Zhou, S., Higgs, D., and Wang, W. (2003) The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. Proc. Natl. Acad. Sci. U.S.A. 100, 10635-10640 (Pubitemid 37140081)
37. Salomoni, P., and Khelifi, A. F. (2006) Daxx: death or survival protein? Trends Cell Biol. 16, 97-104 (Pubitemid 43247405)
38. Croxton, R., Puto, L. A., de Belle, I., Thomas, M., Torii, S., Hanaii, F., Cuddy, M., and Reed, J. C. (2006) Daxx represses expression of a subset of antiapoptotic genes regulated by nuclear factor-κB. Cancer Res. 66, 9026-9035 (Pubitemid 44521121)
39. Puto, L. A., and Reed, J. C. (2008) Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylation. Genes Dev. 22, 998-1010 (Pubitemid 351544239)
40. Lallemand-Breitenbach, V., and de Thé, H. (2010) PML nuclear bodies. Cold Spring Harb. Perspect. Biol. 2, a000661
41. Bernardi, R., and Pandolfi, P. P. (2007) Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell Biol. 8, 1006-1016 (Pubitemid 350174636)
42. Tavalai, N., Papior, P., Rechter, S., and Stamminger, T. (2008) Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. J. Virol. 82, 126-137 (Pubitemid 350309130)
43. McNally, B. A., Trgovcich, J., Maul, G. G., Liu, Y., and Zheng, P. (2008) A role for cytoplasmic PML in cellular resistance to viral infection. PLoS One 3, e2277
44. Hoppe, A., Beech, S. J., Dimmock, J., and Leppard, K. N. (2006) Interaction of the adenovirus type 5 E4 Orf3 protein with promyelocytic leukemia protein isoform II is required for ND10 disruption. J. Virol. 80, 3042-3049 (Pubitemid 43346399)
45. Guccione, E., Lethbridge, K. J., Killick, N., Leppard, K. N., and Banks, L. (2004) HPV E6 proteins interact with specific PML isoforms and allow distinctions to be made between different POD structures. Oncogene 23, 4662-4672 (Pubitemid 38859455)
46. Bischof, O., Nacerddine, K., and Dejean, A. (2005) Human papillomavirus oncoprotein E7 targets the promyelocytic leukemia protein and circumvents cellular senescence via the Rb and p53 tumor suppressor pathways. Mol. Cell. Biol. 25, 1013-1024 (Pubitemid 40165809)
47. Herzer, K., Weyer, S., Krammer, P. H., Galle, P. R., and Hofmann, T. G. (2005) Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells. Cancer Res. 65, 10830-10837 (Pubitemid 41713350)
48. Tsai, K., Thikmyanova, N., Wojcechowskyj, J. A., Delecluse, H. J., and Lieberman, P. M. (2011) EBV tegument protein BNRF1 disrupts DAXXATRX to activate viral early gene transcription. PLoS Pathog. 7, e1002376
49. Regad, T., and Chelbi-Alix, M. K. (2001) Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene 20, 7274-7286 (Pubitemid 33105016)
50. Everett, R. D. (2001) DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 20, 7266-7273
51. Sato, Y., Yoshioka, K., Suzuki, C., Awashima, S., Hosaka, Y., Yewdell, J., and Kuroda, K. (2003) Localization of influenza virus proteins to nuclear dot 10 structures in influenza virus-infected cells. Virology 310, 29-40 (Pubitemid 38352579)
52. Josset, L., Frobert, E., and Rosa-Calatrava, M. (2008) Influenza A replication and host nuclear compartments: many changes and many questions. J. Clin. Virol. 43, 381-390
53. Reinhardt, J., and Wolff, T. (2000) The influenza A virus M1 protein interacts with the cellular receptor of activated C kinase (RACK) 1 and can be phosphorylated by protein kinase C. Vet. Microbiol. 74, 87-100 (Pubitemid 30224647)
54. Ye, Z., Robinson, D., and Wagner, R. R. (1995) Nucleus-targeting domain of the matrix protein (M1) of influenza virus. J. Virol. 69, 1964-1970
55. Whittaker, G., Kemler, I., and Helenius, A. (1995) Hyperphosphorylation of mutant influenza virus matrix protein, M1, causes its retention in the nucleus. J. Virol. 69, 439-445 (Pubitemid 24378822)
56. Halder, U. C., Bagchi, P., Chattopadhyay, S., Dutta, D., and Chawla-Sarkar, M. (2011) Cell death regulation during influenza A virus infection by matrix (M1) protein: a model of viral control over the cellular survival pathway. Cell Death Dis. 2, e197
57. Huprikar, J., and Rabinowitz, S. (1980) A simplified plaque assay for influenza viruses in Madin-Darby kidney (MDCK) cells. J. Virol. Methods. 1, 117-120 (Pubitemid 10109873)
58. Miller, S. A., Dykes, D. D., and Polesky, H. F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215
59. Escobar-Cabrera, E., Lau, D. K., Giovinazzi, S., Ishov, A. M., and McIntosh, L. P. (2010) Structural characterization of the DAXX N-terminal helical bundle domain and its complex with Rassf1C. Structure 18, 1642-1653
60. Hollenbach, A. D., McPherson, C. J., Mientjes, E. J., Iyengar, R., and Grosveld, G. (2002) Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek. J. Cell Sci. 115, 3319-3330 (Pubitemid 34960184)
61. Bialik, S., and Kimchi, A. (2006) The death-associated protein kinases: structure, function, and beyond. Annu. Rev. Biochem. 75, 189-210 (Pubitemid 44118031)
62. Julkunen, I., Sareneva, T., Pirhonen, J., Ronni, T., Melén, K., and Matikainen, S. (2001) Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev. 12, 171-180 (Pubitemid 32588143)
63. Varfolomeev, E., Blankenship, J. W., Wayson, S. M., Fedorova, A. V., Kayagaki, N., Garg, P., Zobel, K., Dynek, J. N., Elliott, L. O., Wallweber, H. J., Flygare, J. A., Fairbrother, W. J., Deshayes, K., Dixit, V. M., and Vucic, D. (2007) IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis. Cell 131, 669-681 (Pubitemid 350087204)
64. Khelifi, A. F., D'Alcontres, M. S., and Salomoni, P. (2005) Daxx is required for stress-induced cell death and JNK activation. Cell Death Differ. 12, 724-733 (Pubitemid 40945980)